MAPK10 and nervous system disorder: Due to the preferential location of JNK3 in neuronal cells, it is a widely studied target for small-drugs used to treat a variety of neurological disorders such as Alzheimer’s disease20, Parkinson’s disease21, Huntington’s disease22 and Amyotrophic lateral sclerosis23.